ATE463566T1 - Tumor- und seneszenzsmarker - Google Patents

Tumor- und seneszenzsmarker

Info

Publication number
ATE463566T1
ATE463566T1 AT01902348T AT01902348T ATE463566T1 AT E463566 T1 ATE463566 T1 AT E463566T1 AT 01902348 T AT01902348 T AT 01902348T AT 01902348 T AT01902348 T AT 01902348T AT E463566 T1 ATE463566 T1 AT E463566T1
Authority
AT
Austria
Prior art keywords
proteins
cell
markers
tumor
sensence
Prior art date
Application number
AT01902348T
Other languages
English (en)
Inventor
Hermann Katinger
Johannes Grillari
Reingard Grabherr
Original Assignee
Polymun Scient Immunbio Forsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymun Scient Immunbio Forsch filed Critical Polymun Scient Immunbio Forsch
Application granted granted Critical
Publication of ATE463566T1 publication Critical patent/ATE463566T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01902348T 2000-01-21 2001-01-22 Tumor- und seneszenzsmarker ATE463566T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17721600P 2000-01-21 2000-01-21
PCT/EP2001/000675 WO2001053472A2 (en) 2000-01-21 2001-01-22 Tumor and senescence marker

Publications (1)

Publication Number Publication Date
ATE463566T1 true ATE463566T1 (de) 2010-04-15

Family

ID=22647679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902348T ATE463566T1 (de) 2000-01-21 2001-01-22 Tumor- und seneszenzsmarker

Country Status (7)

Country Link
US (1) US7202352B2 (de)
EP (1) EP1248839B1 (de)
AT (1) ATE463566T1 (de)
AU (1) AU2001230204A1 (de)
DE (1) DE60141740D1 (de)
ES (1) ES2344400T3 (de)
WO (1) WO2001053472A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090017460A1 (en) * 2007-06-15 2009-01-15 Wyeth Differential expression profiling analysis of cell culture phenotypes and uses thereof
US20090186358A1 (en) * 2007-12-21 2009-07-23 Wyeth Pathway Analysis of Cell Culture Phenotypes and Uses Thereof
DE102012110469A1 (de) * 2012-11-01 2014-05-08 Eugenia Makrantonaki Verfahren zur geschlechtsunabhängigen Bestimmung von Alterung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10511843A (ja) * 1994-07-08 1998-11-17 ニュー イングランド メディカル センター ホスピタルズ インコーポレイテッド Ｅ６結合タンパク質
US5965543A (en) 1996-04-18 1999-10-12 Geron Corporation Senescence responsive transcriptional element
AU4411097A (en) 1996-09-09 1998-03-26 Washington University Modulation of apoptosis by serine phosphorylation of blc-xl/blc-2 associated cell death regulator
US6020136A (en) * 1997-07-18 2000-02-01 The Trustees Of The University Of Pennsylvania Identification of functional transcription factors synthesized in developing neurons
CN1270637A (zh) * 1997-08-08 2000-10-18 华盛顿大学 新的衰老因子基因p23的分离
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor
US5959097A (en) * 1998-11-20 1999-09-28 Isis Pharmaceuticals, Inc. Antisense modulation of MEK2 expression
AU6223700A (en) * 1999-07-19 2001-02-05 Incyte Genomics, Inc. Gtp-binding associated proteins

Also Published As

Publication number Publication date
DE60141740D1 (de) 2010-05-20
US20040086963A1 (en) 2004-05-06
AU2001230204A1 (en) 2001-07-31
EP1248839A2 (de) 2002-10-16
WO2001053472A3 (en) 2002-02-14
WO2001053472A2 (en) 2001-07-26
EP1248839B1 (de) 2010-04-07
ES2344400T3 (es) 2010-08-26
US7202352B2 (en) 2007-04-10

Similar Documents

Publication Publication Date Title
ATE420160T1 (de) Modifizierte rekombinante vacciniaviren, verwendungen davon
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
ATE474052T1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
ECSP024210A (es) Moléculas de anticuerpo que tienen especificidad por el factor de necrosis tumoral alfa humano, y uso de las mismas
WO2004000094A3 (en) Predictive markers in cancer therapy
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
MXPA03010523A (es) Anticuerpos especificos para cd44v6.
ATE514718T1 (de) Peptabody für krebsbehandlung
WO2002092013A3 (en) Methods for treating liver disease and liver damage with growth hormone and foxm1b
IL149416A0 (en) Human enzymes of the metalloprotease family
ATE463566T1 (de) Tumor- und seneszenzsmarker
BR0312483A (pt) Anticorpos e seus usos
WO2004013313A3 (en) Antisense nucleic acids
AU2001235761A1 (en) Diagnosis of breast cancer using bcmp-11 as marker
SE0000597D0 (sv) Novel antibody
WO2001000854A3 (en) Chimeric proteins mediating targeted apoptosis
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
ATE399794T1 (de) Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
ATE466023T1 (de) Mannose-spezifische adhesinen und deren vervendung
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
DE60028750D1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
ATE315406T1 (de) Semi-allogene antitumor-vakzine mit hla-haplo- identischen antigen-präsentierenden zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1248839

Country of ref document: EP